Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) SHH

Currency In CNY

AD

Valuation

Market Cap13.55B
Enterprise Value10.73B
P/E Ratio20.41
PEG Ratio-0.42
Price/Sales Ratio1.29
Price/Book Ratio0.79
Enterprise/Revenue1.03
Enterprise/EBITDA6.75

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.06
Operating Margin0.09
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue9.36B
Revenue/Share6.28
Gross Profit3.04B
EBITDA2.05B
Net Income944.38M
Diluted EPS0.7

Balance Sheet

Total Cash7.42B
Total Cash/Share5.53
Total Debt1.32B
Total Debt/Equity0.1
Current Ratio3.53
Book Value Per Share11.89

Price History

52-Week Change-25.51
52-Week High11.09
52-Week Low7.67
Moving Average 50 Days8.43
Moving Average 200 Days9.36

Statistics

Average Volume7.84M
Shares Outstanding1.34B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield3.09
Payout Ratio1.25
Last Split Factor2:1
Last Split DateMay 25, 2017
AD